Pappas Capital invests exclusively in the life science sector. For 27 years we have been investing in and building innovative companies that are developing the next generation of life science products and technologies. We’ve invested in more than 85 companies across the United States and Canada, in fields that span the range of human disease. The 22 products our companies have brought to market – for treating such conditions as melanoma, ovarian cancer, and hemophilia, to name a few – have been used throughout the world to treat tens of thousands of patients and account for billions of dollars of revenue.
Whether you’re looking for capital or have capital to invest, contact us and learn how we can put our expertise to work for you.
Whether you’re looking for capital or have capital to invest, contact us and learn how we can put our expertise to work for you.
Location: United States, North Carolina, Durham
Employees: 11-50
Founded date: 1994
Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 31.03.2023 | Horizon Qu... | horizonquantum.com | $21.33M | Singapore |
Mentions in press and media 18
| Date | Title | Description |
| 06.12.2021 | Better.com’s morale and SPAC merger success in question after CEO’s unruly comments | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Good morning, Term Sheeters. Paid Content How A.I. can reshape jobs to enable more value-add From... |
| 06.12.2021 | Better.com’s morale and SPAC merger success in question after CEO’s unruly comments | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Good morning, Term Sheeters. Paid Content What companies need to know about cloud modernization F... |
| 05.11.2020 | Pappas Capital Portfolio Company VelosBio to be Acquired by Merck | |
| 05.11.2020 | MERCK & CO., INC. Pappas Capital : Portfolio Company VelosBio to be Acquired by Merck | RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2020 /PRNewswire/ -- Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. ("VelosBio" or the "Compa... |
| 05.11.2020 | Merck paying $2.75B for cancer therapeutics firm VelosBio | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 11.05.2020 | Pappas Capital : Portfolio Company VelosBio to be Acquired by Merck | RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2020 /PRNewswire/ -- Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. ("VelosBio" or the "Compa... |
| 11.09.2019 | Pappas Ventures Appoints Alex Arfaei as Partner | Pappas Capital, a leading investor in early-stage life sciences companies, announced today that Alex Arfaei has joined the firm as a Partner of Pappas Ventures. In his role, Mr. Arfaei will be responsible for helping to identify and evaluat... |
| 17.01.2019 | Pappas Capital Raises $85.7M for New Fund | A Durham, North Carolina venture capital firm investor, Arthur ‘Art’ Pappas, has raised $85.7 million in a fund to invest in companies, according to a filing with the Securities and Exchange Commission. Pappas, managing partner and founder ... |
| 11.04.2018 | Term Sheet — Wednesday, April 11 | CRYPTO CAPITAL HOUSEKEEPING: I’ll be on vacation until April 20, so my wonderful colleague Lucinda Shen will be compiling the deals below. So if you have a deal for Term Sheet, please send it to her at [email protected]. Thank you in... |
| 04.01.2018 | Term Sheet — Thursday, January 4 | TAKING A HIATUS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop In other words, the seed stage has become increasingly crowded, competitive, and expensive. VCs are raising larger funds, writi... |
Show more